A citation-based method for searching scientific literature

Emilie Bousquet Mur, Sara Bernardo, Laura Papon, Maicol Mancini, Eric Fabbrizio, Marion Goussard, Irene Ferrer, Anais Giry, Xavier Quantin, Jean-Louis Pujol, Olivier Calvayrac, Herwig P Moll, Yaël Glasson, Nelly Pirot, Andrei Turtoi, Marta Cañamero, Kwok-Kin Wong, Yosef Yarden, Emilio Casanova, Jean-Charles Soria, Jacques Colinge, Christian W Siebel, Julien Mazieres, Gilles Favre, Luis Paz-Ares, Antonio Maraver. J Clin Invest 2020
Times Cited: 13







List of co-cited articles
77 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


EGFR blockade enriches for lung cancer stem-like cells through Notch3-dependent signaling.
Rajeswara Rao Arasada, Joseph M Amann, Mohammad A Rahman, Stacey S Huppert, David P Carbone. Cancer Res 2014
87
30

Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer.
Jean-Charles Soria, Yuichiro Ohe, Johan Vansteenkiste, Thanyanan Reungwetwattana, Busyamas Chewaskulyong, Ki Hyeong Lee, Arunee Dechaphunkul, Fumio Imamura, Naoyuki Nogami, Takayasu Kurata,[...]. N Engl J Med 2018
30



EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.
Susumu Kobayashi, Titus J Boggon, Tajhal Dayaram, Pasi A Jänne, Olivier Kocher, Matthew Meyerson, Bruce E Johnson, Michael J Eck, Daniel G Tenen, Balázs Halmos. N Engl J Med 2005
23

Notch promotes radioresistance of glioma stem cells.
Jialiang Wang, Timothy P Wakeman, Justin D Lathia, Anita B Hjelmeland, Xiao-Fan Wang, Rebekah R White, Jeremy N Rich, Bruce A Sullenger. Stem Cells 2010
431
15

The cellular and molecular origin of tumor-associated macrophages.
Ruth A Franklin, Will Liao, Abira Sarkar, Myoungjoo V Kim, Michael R Bivona, Kang Liu, Eric G Pamer, Ming O Li. Science 2014
783
15

Synergistic effect of the γ-secretase inhibitor PF-03084014 and docetaxel in breast cancer models.
Cathy C Zhang, Zhengming Yan, Qing Zong, Douglas D Fang, Cory Painter, Qin Zhang, Enhong Chen, Maruja E Lira, Annette John-Baptiste, James G Christensen. Stem Cells Transl Med 2013
63
15

A conserved role for Notch signaling in priming the cellular response to Shh through ciliary localisation of the key Shh transducer Smo.
Magdalena Stasiulewicz, Shona D Gray, Ioanna Mastromina, Joana C Silva, Mia Björklund, Philip A Seymour, David Booth, Calum Thompson, Richard J Green, Emma A Hall,[...]. Development 2015
59
15

Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
Guo Dai, Shuang Deng, Weichun Guo, Ling Yu, Jian Yang, Sheng Zhou, Tian Gao. Mol Carcinog 2019
27
15

Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitors.
Nithya Krishnamurthy, Razelle Kurzrock. Cancer Treat Rev 2018
507
15

Notch post-translationally regulates β-catenin protein in stem and progenitor cells.
Chulan Kwon, Paul Cheng, Isabelle N King, Peter Andersen, Lincoln Shenje, Vishal Nigam, Deepak Srivastava. Nat Cell Biol 2011
193
15

Notch3-dependent β-catenin signaling mediates EGFR TKI drug persistence in EGFR mutant NSCLC.
Rajeswara Rao Arasada, Konstantin Shilo, Tadaaki Yamada, Jianying Zhang, Seiji Yano, Rashelle Ghanem, Walter Wang, Shinji Takeuchi, Koji Fukuda, Nobuyuki Katakami,[...]. Nat Commun 2018
33
15

Notch3 and pre-TCR interaction unveils distinct NF-kappaB pathways in T-cell development and leukemia.
Alessandra Vacca, Maria Pia Felli, Rocco Palermo, Giuseppina Di Mario, Angelica Calce, Monica Di Giovine, Luigi Frati, Alberto Gulino, Isabella Screpanti. EMBO J 2006
114
15

NOTCH signaling is activated in and contributes to resistance in enzalutamide-resistant prostate cancer cells.
Elia Farah, Chaohao Li, Lijun Cheng, Yifan Kong, Nadia A Lanman, Pete Pascuzzi, Gabrielle Renee Lorenz, Yanquan Zhang, Nihal Ahmad, Lang Li,[...]. J Biol Chem 2019
36
15

Reversal of docetaxel resistance in prostate cancer by Notch signaling inhibition.
Shi Qiu, Linghui Deng, Yige Bao, Kun Jin, Xiang Tu, Jiakun Li, Xinyang Liao, Zhenhua Liu, Lu Yang, Qiang Wei. Anticancer Drugs 2018
16
15

Notch controls generation and function of human effector CD8+ T cells.
Loes M Kuijk, Marleen I Verstege, Niels V Rekers, Sven C Bruijns, Erik Hooijberg, Bart O Roep, Tanja D de Gruijl, Yvette van Kooyk, Wendy W J Unger. Blood 2013
37
15

Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases.
Ila Joshi, Lisa M Minter, Janice Telfer, Renée M Demarest, Anthony J Capobianco, Jon C Aster, Piotr Sicinski, Abdul Fauq, Todd E Golde, Barbara A Osborne. Blood 2009
136
15

Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis).
Shivaani Kummar, Geraldine O'Sullivan Coyne, Khanh T Do, Baris Turkbey, Paul S Meltzer, Eric Polley, Peter L Choyke, Robert Meehan, Rasa Vilimas, Yvonne Horneffer,[...]. J Clin Oncol 2017
93
15

Therapeutics strategies against cancer stem cell in breast cancer.
Faezeh Ghasemi, Parisa Zia Sarabi, Seyyed Shamsadin Athari, Abdolreza Esmaeilzadeh. Int J Biochem Cell Biol 2019
26
15

Notch pathway inhibition with LY3039478 in soft tissue sarcoma and gastrointestinal stromal tumours.
Olivier Mir, Analia Azaro, Jaime Merchan, Rashmi Chugh, Jonathan Trent, Jordi Rodon, Ute Ohnmacht, J T Diener, Claire Smith, Eunice Yuen,[...]. Eur J Cancer 2018
19
15

Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy.
Shannon M McAuliffe, Stefanie L Morgan, Gregory A Wyant, Lieu T Tran, Katherine W Muto, Yu Sarah Chen, Kenneth T Chin, Justin C Partridge, Barish B Poole, Kuang-Hung Cheng,[...]. Proc Natl Acad Sci U S A 2012
232
15

Wnt-Notch signalling crosstalk in development and disease.
Giovanna M Collu, Ana Hidalgo-Sastre, Keith Brennan. Cell Mol Life Sci 2014
122
15

Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways.
Mirjam C Boelens, Tony J Wu, Barzin Y Nabet, Bihui Xu, Yu Qiu, Taewon Yoon, Diana J Azzam, Christina Twyman-Saint Victor, Brianne Z Wiemann, Hemant Ishwaran,[...]. Cell 2014
529
15

The Varied Roles of Notch in Cancer.
Jon C Aster, Warren S Pear, Stephen C Blacklow. Annu Rev Pathol 2017
326
15

A phase II study of RO4929097 in metastatic colorectal cancer.
Jonathan R Strosberg, Timothy Yeatman, Jill Weber, Domenico Coppola, Michael J Schell, Gang Han, Khaldoun Almhanna, Richard Kim, Tiffany Valone, Helen Jump,[...]. Eur J Cancer 2012
96
15

Structural basis for autoinhibition of Notch.
Wendy R Gordon, Didem Vardar-Ulu, Gavin Histen, Cheryll Sanchez-Irizarry, Jon C Aster, Stephen C Blacklow. Nat Struct Mol Biol 2007
240
15

The complex world of WNT receptor signalling.
Christof Niehrs. Nat Rev Mol Cell Biol 2012
913
15

Progressive and Prognosis Value of Notch Receptors and Ligands in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Yingshi Zhang, Dandan Li, Fan Feng, Li An, Fuhai Hui, Dasheng Dang, Qingchun Zhao. Sci Rep 2017
23
15

The many facets of Notch ligands.
B D'Souza, A Miyamoto, G Weinmaster. Oncogene 2008
320
15

Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival.
Andrew Baker, Debra Wyatt, Maurizio Bocchetta, Jun Li, Aleksandra Filipovic, Andrew Green, Daniel S Peiffer, Suzanne Fuqua, Lucio Miele, Kathy S Albain,[...]. Oncogene 2018
59
15

Phase 2 study of RO4929097, a gamma-secretase inhibitor, in metastatic melanoma: SWOG 0933.
Sylvia M Lee, James Moon, Bruce G Redman, Tarek Chidiac, Lawrence E Flaherty, Yuanyuan Zha, Megan Othus, Antoni Ribas, Vernon K Sondak, Thomas F Gajewski,[...]. Cancer 2015
65
15

TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms.
L W Ellisen, J Bird, D C West, A L Soreng, T C Reynolds, S D Smith, J Sklar. Cell 1991
15

A novel inhibitor of ADAM17 sensitizes colorectal cancer cells to 5-Fluorouracil by reversing Notch and epithelial-mesenchymal transition in vitro and in vivo.
Dan-Dan Li, Chang-Hao Zhao, Huai-Wei Ding, Qiong Wu, Tian-Shu Ren, Jian Wang, Cong-Qin Chen, Qing-Chun Zhao. Cell Prolif 2018
29
15

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
15

Notch signalling regulates stem cell numbers in vitro and in vivo.
Andreas Androutsellis-Theotokis, Ronen R Leker, Frank Soldner, Daniel J Hoeppner, Rea Ravin, Steve W Poser, Maria A Rueger, Soo-Kyung Bae, Raja Kittappa, Ronald D G McKay. Nature 2006
756
15

Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update.
Naoko Takebe, Lucio Miele, Pamela Jo Harris, Woondong Jeong, Hideaki Bando, Michael Kahn, Sherry X Yang, S Percy Ivy. Nat Rev Clin Oncol 2015
767
15

Therapeutic modulation of Notch signalling--are we there yet?
Emma R Andersson, Urban Lendahl. Nat Rev Drug Discov 2014
326
15

Notch signaling: cell fate control and signal integration in development.
S Artavanis-Tsakonas, M D Rand, R J Lake. Science 1999
15

EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.
Tsukasa Shibue, Robert A Weinberg. Nat Rev Clin Oncol 2017
15

HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
Yuanyuan Yan, Fangxiao Liu, Li Han, Lin Zhao, Jianjun Chen, Olufunmilayo I Olopade, Miao He, Minjie Wei. J Exp Clin Cancer Res 2018
82
15

SMO Gene Amplification and Activation of the Hedgehog Pathway as Novel Mechanisms of Resistance to Anti-Epidermal Growth Factor Receptor Drugs in Human Lung Cancer.
Carminia Maria Della Corte, Claudio Bellevicine, Giovanni Vicidomini, Donata Vitagliano, Umberto Malapelle, Marina Accardo, Alessio Fabozzi, Alfonso Fiorelli, Morena Fasano, Federica Papaccio,[...]. Clin Cancer Res 2015
84
15

Bronchial and peripheral murine lung carcinomas induced by T790M-L858R mutant EGFR respond to HKI-272 and rapamycin combination therapy.
Danan Li, Takeshi Shimamura, Hongbin Ji, Liang Chen, Henry J Haringsma, Kate McNamara, Mei-Chih Liang, Samanthi A Perera, Sara Zaghlul, Christa L Borgman,[...]. Cancer Cell 2007
173
15

Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment.
Puyu Shi, You-Take Oh, Guojing Zhang, Weilong Yao, Ping Yue, Yikun Li, Rajani Kanteti, Jacob Riehm, Ravi Salgia, Taofeek K Owonikoko,[...]. Cancer Lett 2016
111
15

Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study.
Lecia V Sequist, Ji-Youn Han, Myung-Ju Ahn, Byoung Chul Cho, Helena Yu, Sang-We Kim, James Chih-Hsin Yang, Jong Seok Lee, Wu-Chou Su, Dariusz Kowalski,[...]. Lancet Oncol 2020
168
15

Osimertinib or Platinum-Pemetrexed in EGFR T790M-Positive Lung Cancer.
Tony S Mok, Yi-Long Wu, Myung-Ju Ahn, Marina C Garassino, Hye R Kim, Suresh S Ramalingam, Frances A Shepherd, Yong He, Hiroaki Akamatsu, Willemijn S M E Theelen,[...]. N Engl J Med 2017
15

Emerging Treatment Paradigms for EGFR-Mutant Lung Cancers Progressing on Osimertinib: A Review.
Andrew J Piper-Vallillo, Lecia V Sequist, Zofia Piotrowska. J Clin Oncol 2020
63
15

Osimertinib As First-Line Treatment of EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer.
Suresh S Ramalingam, James C-H Yang, Chee Khoon Lee, Takayasu Kurata, Dong-Wan Kim, Thomas John, Naoyuki Nogami, Yuichiro Ohe, Helen Mann, Yuri Rukazenkov,[...]. J Clin Oncol 2018
309
15

Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancers.
Collin M Blakely, Thomas B K Watkins, Wei Wu, Beatrice Gini, Jacob J Chabon, Caroline E McCoach, Nicholas McGranahan, Gareth A Wilson, Nicolai J Birkbak, Victor R Olivas,[...]. Nat Genet 2017
306
15

AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer.
Pasi A Jänne, James Chih-Hsin Yang, Dong-Wan Kim, David Planchard, Yuichiro Ohe, Suresh S Ramalingam, Myung-Ju Ahn, Sang-We Kim, Wu-Chou Su, Leora Horn,[...]. N Engl J Med 2015
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.